Dimakakos, E, Gomatou, G, Catalano, M, Olinic, DM, Spyropoulos, AC, Falanga, A, Maraveyas, A, Liew, A, Schulman, S, Belch, J, Gerotziafas, G, Marschang, P, Cosmi, B, Spaak, J, Syrigos, K, Antic, D, Blinc, A, Boc, V, Boccardo, F, Brodmann, M, Carpentier, P, Celovska, D, De Marchi, S, Dimitrov, G, Farkas, K, Fionik, O, Fyta, E, Gkiozos, I, Gottsater, A, Gresele, P, Hamade, A, Heiss, C, Karahan, O, Karakatsanis, S, Kavousi, M, Kollias, A, Kolossvary, E, Kotteas, E, Kozak, M
, Kroon, A, Kubat, E, Lefkou, E, Lessani, G, Manu, C, Mazzolai, L, Milic, D, Nancheva, J, Pantazopoulos, K, Patriarcheas, V, Pazvanska, E & CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP 2022, '
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art',
Anticancer Research, vol. 42, no. 7, 15815, pp. 3261-3274.
https://doi.org/10.21873/anticanres.15815